syngo DynaCT with intravenous contrast injection in Dual Volume mode offers a technique that is less impacted by these artifacts
syngo DynaCT with intravenous contrast injection in Dual Volume mode offers a technique that is less impacted by these artifacts
Arterial bleeding after Gamma nail insertion in right hip
Arterial bleeding after Gamma nail insertion in right hip
syngo Embolization Guidance with arterial contrast injection facilitates selective prostate artery catheterization, which has the potential to reduce dose and contrast medium
syngo Embolization Guidance with arterial contrast injection facilitates selective prostate artery catheterization, which has the potential to reduce dose and contrast medium
syngo DynaCT 360 offers more coverage compared to conventional cone-beam CT to evaluate portal vein, hepatic vein and other vascular structures in the abdomen
syngo DynaCT 360 offers more coverage compared to conventional cone-beam CT to evaluate portal vein, hepatic vein and other vascular structures in the abdomen
For the use of syngo iFlow, 4 F/s Digital Subtraction Angiograph (DSA) run is sufficient. No separate DSA runs are necessary.
For the use of syngo iFlow, 4 F/s Digital Subtraction Angiograph (DSA) run is sufficient. No separate DSA runs are necessary.
Persistent type IIb endoleak after EVAR treatment
Persistent type IIb endoleak after EVAR treatment
High-resolution flat-detector computed tomography improves assessment of stent deployment and could reduce the risk of complications in symptomatic intracranial atherosclerotic stenosis (ICAS).
High-resolution flat-detector computed tomography improves assessment of stent deployment and could reduce the risk of complications in symptomatic intracranial atherosclerotic stenosis (ICAS).
Pulmonary angiograms are still the established gold standard for
diagnostic workup in patients with CTEPH. syngo DynaCT is likely to give additional information about chronic embolism by depicting web stenoses and occlusions.
Pulmonary angiograms are still the established gold standard for
diagnostic workup in patients with CTEPH. syngo DynaCT is likely to give additional information about chronic embolism by depicting web stenoses and occlusions.
Integrating intraprocedural 3.0-T MRI into acute ischemic stroke treatment can be a considered a feasible and guided decisions of whether or not to continue thrombectomy.
Integrating intraprocedural 3.0-T MRI into acute ischemic stroke treatment can be a considered a feasible and guided decisions of whether or not to continue thrombectomy.
A 51-year-old male presented with hepatocellular BCLC stage A carcinoma. Arterial hyperenhancement with portal venous and delayed phase washout centrally consistent with HCC was diagnosed.
A 51-year-old male presented with hepatocellular BCLC stage A carcinoma. Arterial hyperenhancement with portal venous and delayed phase washout centrally consistent with HCC was diagnosed.
A 70-year-old male was diagnosed with hepatitis C virus positive cirrhosis/recurrent HCC. A dual-phase syngo DynaCT was performed during hepatic arteriography just before
A 70-year-old male was diagnosed with hepatitis C virus positive cirrhosis/recurrent HCC. A dual-phase syngo DynaCT was performed during hepatic arteriography just before
A 59-year-old male was diagnosed with metastatic CRC to spleen. An Angio-CT suite equipped with a CT scanner and a flat-panel c-arm angiography system was used to perform combined embolization and ablation procedure.
A 59-year-old male was diagnosed with metastatic CRC to spleen. An Angio-CT suite equipped with a CT scanner and a flat-panel c-arm angiography system was used to perform combined embolization and ablation procedure.
A 65-year-old male was diagnosed with CRC. After 24 months of first-line treatment, the CT scanner showed lung metastasis. Syngo iguide® software was used for needle path planning and syngo InSpace 3D (5s DR protocol, 133 projections) was performed.
A 65-year-old male was diagnosed with CRC. After 24 months of first-line treatment, the CT scanner showed lung metastasis. Syngo iguide® software was used for needle path planning and syngo InSpace 3D (5s DR protocol, 133 projections) was performed.
A 70-year-old male with multifocal hepatocellular carcinoma. Preoperative MRI imaging showed two hypervascular lesions. Digital subtraction angiography (DSA) was performed.
A 70-year-old male with multifocal hepatocellular carcinoma. Preoperative MRI imaging showed two hypervascular lesions. Digital subtraction angiography (DSA) was performed.
A 69-year-old male with HCC (hepatocellular carcinoma) and HCV (Hepatitis bC virus)-positive hepatic cirrhosis. HCC recurrence was found by ultra-sonography and dynamic contrast-enhanced CT scan during regular follow-up.
A 69-year-old male with HCC (hepatocellular carcinoma) and HCV (Hepatitis bC virus)-positive hepatic cirrhosis. HCC recurrence was found by ultra-sonography and dynamic contrast-enhanced CT scan during regular follow-up.
A 78-year-old male with alcohol-induced liver cirrhosis and a single HCC (8 cm) in the right liver lobe. MR imaging represented residual tumor tissue.
A 78-year-old male with alcohol-induced liver cirrhosis and a single HCC (8 cm) in the right liver lobe. MR imaging represented residual tumor tissue.
A 63-year-old female with liver metastases from breast cancer. SIRT (selective internal radiation therapy) of the right liver lobe was performed. DEB-TACE was done for the left liver lobe. Syngo DynaCT was performed in order to confirm catheter position before embolization, which revealed contrast enhancement in the distal esophagus.
A 63-year-old female with liver metastases from breast cancer. SIRT (selective internal radiation therapy) of the right liver lobe was performed. DEB-TACE was done for the left liver lobe. Syngo DynaCT was performed in order to confirm catheter position before embolization, which revealed contrast enhancement in the distal esophagus.
A 64-year-old male patient with HCV (Hepatitis C Virus)cirrhosis (Child-Pugh B7) complicated by hepatic hydrothorax, ascites, and hepatocellular carcinoma (HCC). Previously underwent hepatic trans-arterial chemoembolization (TACE).
A 64-year-old male patient with HCV (Hepatitis C Virus)cirrhosis (Child-Pugh B7) complicated by hepatic hydrothorax, ascites, and hepatocellular carcinoma (HCC). Previously underwent hepatic trans-arterial chemoembolization (TACE).